Assay News and Research

RSS
Study explores favorable signatures for specific RNA motif recognition by SARS-CoV-2 nucleocapsid

Study explores favorable signatures for specific RNA motif recognition by SARS-CoV-2 nucleocapsid

24 Mar 2022
Study finds that Omicron variant preferentially uses the endosome pathway through mutation in the spike protein

Study finds that Omicron variant preferentially uses the endosome pathway through mutation in the spike protein

24 Mar 2022
Study identified multiple siRNAs spanning the SARS-CoV-2 genome with potent antiviral activity

Study identified multiple siRNAs spanning the SARS-CoV-2 genome with potent antiviral activity

24 Mar 2022
Uptake of SARS-CoV-2 spike protein in human cerebrovascular cells

Uptake of SARS-CoV-2 spike protein in human cerebrovascular cells

24 Mar 2022
Non-hormonal male contraceptive effectively prevents pregnancy in mice

Non-hormonal male contraceptive effectively prevents pregnancy in mice

24 Mar 2022
Study evaluates risk estimates of myocarditis and pericarditis from mRNA-1273 and BNT162b2 vaccines

Study evaluates risk estimates of myocarditis and pericarditis from mRNA-1273 and BNT162b2 vaccines

23 Mar 2022
Researchers investigate Galectin-9 as a new treatment target for COVID-19

Researchers investigate Galectin-9 as a new treatment target for COVID-19

23 Mar 2022
Study confirms no preexisting B-cell immunity against SARS-CoV-2 in pre-pandemic samples

Study confirms no preexisting B-cell immunity against SARS-CoV-2 in pre-pandemic samples

23 Mar 2022
TTUHSC researcher secures $1.9 million grant to investigate vulnerabilities in ALT cancers

TTUHSC researcher secures $1.9 million grant to investigate vulnerabilities in ALT cancers

23 Mar 2022
Study reveals new opportunities for using small molecule drugs to target KRAS mutants

Study reveals new opportunities for using small molecule drugs to target KRAS mutants

23 Mar 2022
Importance of Numb-associated kinases in SARS-CoV-2 infection

Importance of Numb-associated kinases in SARS-CoV-2 infection

23 Mar 2022
Monitoring SARS-CoV-2 Ct values during early infection

Monitoring SARS-CoV-2 Ct values during early infection

22 Mar 2022
Powerful tool to monitor membrane proteins trafficking for drug discovery

Powerful tool to monitor membrane proteins trafficking for drug discovery

22 Mar 2022
The obstacles to developing high-throughput 3D wound healing models

The obstacles to developing high-throughput 3D wound healing models

From PromoCell 22 Mar 2022
Key mechanism that increases drug tolerance among microbial communities revealed

Key mechanism that increases drug tolerance among microbial communities revealed

22 Mar 2022
Study evaluates interactions between SARS-CoV-2 proteins and viral and host RNA

Study evaluates interactions between SARS-CoV-2 proteins and viral and host RNA

22 Mar 2022
Angiotensin-converting enzyme 2 allosteric binders found to be effective against SARS-CoV-2

Angiotensin-converting enzyme 2 allosteric binders found to be effective against SARS-CoV-2

22 Mar 2022
Human parainfluenza type 3 virus outbreak in Seoul during SARS-CoV-2 pandemic

Human parainfluenza type 3 virus outbreak in Seoul during SARS-CoV-2 pandemic

22 Mar 2022
New research proves benefit of vaccination after recovery from COVID-19

New research proves benefit of vaccination after recovery from COVID-19

22 Mar 2022
SARS-CoV-2 infection risk among dialysis patients during Omicron surge

SARS-CoV-2 infection risk among dialysis patients during Omicron surge

22 Mar 2022

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback